These qualitative results, along with the protective effect of DNA-PK inhibition against asthma [8], ALI, and DTH, demonstrate the possibility that the kinase is a component of disease manifestation and potentially a driver of inflammatory conditions. This evidence concerns the gene PRKDC and asthma.